| 1. | | Not yet recruiting | Adoptive Immunotherapy and Interleukin-2 in Treating Patients With Recurrent Accelerated or Blast Phase Chronic Myelogenous Leukemia After Undergoing Allogeneic Stem Cell Transplantation
Conditions: accelerated phase chronic myelogenous leukemia; blastic phase chronic myelogenous leukemia; relapsing chronic myelogenous leukemia; ... |
| 2. | | Recruiting | Alemtuzumab, Total-Body Irradiation, and Fludarabine Followed By Donor Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer
Conditions: childhood Hodgkin's lymphoma; childhood non-Hodgkin's lymphoma; hematopoietic and lymphoid cancer |
| 3. | | Recruiting | Arsenic Trioxide and Etanercept in Treating Patients With Myelodysplastic Syndromes
Conditions: de novo myelodysplastic syndromes; previously treated myelodysplastic syndromes; secondary myelodysplastic syndromes; ... |
| 4. | | Recruiting | Biological Therapy After Chemotherapy in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma
Conditions: recurrent grade 1 follicular lymphoma; recurrent grade 2 follicular lymphoma; recurrent grade 3 follicular lymphoma |
| 5. | | Not yet recruiting | Biological Therapy in Treating Patients With Advanced Acute Myeloid Leukemia or Acute Lymphoblastic Leukemia Who Are Undergoing Stem Cell Transplantation
Conditions: adult acute lymphoblastic leukemia; adult acute myeloid leukemia; childhood acute lymphoblastic leukemia; ... |
| 6. | | Recruiting | Bone Marrow Transplantation in Treating Children With Sickle Cell Disease
Condition: Sickle Cell Anemia |
| 7. | | Recruiting | Chemotherapy Followed by Donor White Blood Cells Plus Interleukin-2 in Treating Patients With Acute Myeloid or Lymphocytic Leukemia
Conditions: adult acute lymphoblastic leukemia; adult acute myeloid leukemia; childhood acute lymphoblastic leukemia; childhood acute myeloid leukemia |
| 8. | | Recruiting | Chemotherapy, Low-Dose Total-Body Irradiation, and Peripheral Stem Cell Transplantation Followed By Chemotherapy and Donor Lymphocyte Infusion in Treating Older Patients With Chronic Myeloid Leukemia
Conditions: chronic phase chronic myelogenous leukemia; accelerated phase chronic myelogenous leukemia; ... |
| 9. | | Recruiting | Combination Chemotherapy and Antithymocyte Globulin in Reducing Graft-Versus-Host Disease in Patients Undergoing Donor Stem Cell Transplantation For Myelodysplastic Syndrome or Myeloproliferative Disorder
Conditions: acute leukemia; chronic myeloproliferative disorders; Graft Versus Host Disease; myelodysplastic and myeloproliferative disease |
| 10. | | Recruiting | Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation and Low-Dose Interleukin-2 in Treating Patients With Acute Myelogenous Leukemia
Conditions: adult acute myeloid leukemia; childhood acute myeloid leukemia |
| 11. | | Recruiting | Combining Chemotherapy, Tacrolimus, Mycophenolate Mofetil, and Radiation Therapy with Donor Bone Marrow Transplantation in Treating Patients with Hematologic Cancer
Conditions: childhood Hodgkin's lymphoma; childhood non-Hodgkin's lymphoma; Leukemia; Lymphoma; myelodysplastic and myeloproliferative diseases; ... |
| 12. | | Recruiting | Donor Lymphocyte Infusion in Treating Patients With Persistent, Relapsed, or Progressing Cancer After Allogeneic Transplantation
Conditions: Cancer; Graft Versus Host Disease |
| 13. | | Recruiting | Donor Peripheral Stem Cell Transplantation in Treating Patients With Acute Lymphoblastic Leukemia
Conditions: adult acute lymphoblastic leukemia in remission; childhood acute lymphoblastic leukemia in remission |
| 14. | | Recruiting | Donor Peripheral Stem Cell Transplantation in Treating Patients With Myelodysplastic Syndrome, Acute Myeloid Leukemia, or Myeloproliferative Disorder
Conditions: acute leukemia; atypical chronic myeloid leukemia; chronic leukemia; chronic myeloproliferative disorders; ... |
| 15. | | Recruiting | Fludarabine and Total-Body Irradiation Followed By Donor Peripheral Stem Cell Transplantation in Treating Patients With Acute Lymphoblastic Leukemia or Chronic Myelogenous Leukemia That Has Responded to Treatment With Imatinib Mesylate
Conditions: recurrent childhood acute lymphoblastic leukemia; recurrent adult acute lymphoblastic leukemia; blastic phase chronic myelogenous leukemia; ... |
| 16. | | Recruiting | Fludarabine, Low-Dose Total-Body Irradiation, Donor Stem Cell Transplantation, and Immunosuppression Therapy in Treating Patients Who Have Fanconi’s Anemia
Conditions: Fanconi's Anemia; adult acute myeloid leukemia; childhood acute myeloid leukemia; Graft Versus Host Disease; Myelodysplastic Syndromes |
| 17. | | Recruiting | Gemtuzumab Ozogamicin and Cyclosporine in Treating Older Patients With Relapsed Acute Myeloid Leukemia
Conditions: adult acute erythroid leukemia; adult acute monoblastic and acute monocytic leukemia; adult acute myeloid leukemia |
| 18. | | Recruiting | Immunosuppression With Mycophenolate Mofetil and Cyclosporine in Preventing Graft-Versus-Host Disease in Patients Undergoing Donor Peripheral Stem Cell Transplantation for Hematologic Malignancies or Metastatic Renal Cell Carcinoma
Conditions: childhood Hodgkin's lymphoma; childhood non-Hodgkin's lymphoma; Graft Versus Host Disease; hematopoietic and lymphoid cancer; ... |
| 19. | | Recruiting | Iodine I 131 Tositumomab Followed by Autologous Stem Cell Transplantation in Treating Older Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma
Condition: adult non-Hodgkin's lymphoma |
| 20. | | Recruiting | Iodine I 131 Tositumomab, Etoposide, and Cyclophosphamide Followed by Autologous Stem Cell Transplantation in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma
Condition: adult non-Hodgkin's lymphoma |
| 21. | | Recruiting | Low-Dose Chemotherapy and Radiation Therapy Before Allogeneic Stem Cell Transplantation in Treating Patients With Refractory Chronic Lymphocytic Leukemia
Condition: refractory chronic lymphocytic leukemia |
| 22. | | Recruiting | Peripheral Stem Cell Transplantation in Treating Older Patients With Acute Myeloid Leukemia
Conditions: adult acute monoblastic and acute monocytic leukemia; adult acute myeloid leukemia; secondary acute myeloid leukemia |
| 23. | | Recruiting | Peripheral Stem Cell Transplantation, White Blood Cell Infusions, Chemotherapy, and Radiation Therapy in Treating Patients With Recurrent Metastatic Cervical or Vaginal Cancer
Conditions: Cervical Cancer; Vaginal Cancer |
| 24. | | Recruiting | Peripheral Stem Transplantation in Treating Patients With Refractory or Relapsed Lymphoma
Conditions: childhood Hodgkin's lymphoma; childhood non-Hodgkin's lymphoma; Graft Versus Host Disease; Lymphoma |
| 25. | | Recruiting | Pilot Study of Allogeneic Bone Marrow Transplantation Plus Cyclosporine and Mycophenolate Mofetil to Induce Mixed Hematopoietic Chimerism in Patients With Primary T-Cell Immunodeficiency Disorders
Conditions: Purine-Pyrimidine Metabolism, Inborn Errors; Wiskott-Aldrich Syndrome; Bare Lymphocyte Syndrome; Lymphopenia; Job's Syndrome; DiGeorge Syndrome; ... |
| 26. | | Recruiting | Pilot Study of Total Body Irradiation in Combination With Cyclophosphamide, Anti-thymocyte Globulin, and Autologous CD34-Selected Peripheral Blood Stem Cell Transplantation in Children With Refractory Autoimmune Disorders
Conditions: Systemic Sclerosis; Systemic Lupus Erythematosus; Dermatomyositis; Juvenile Rheumatoid Arthritis; Autoimmune Diseases |
| 27. | | Recruiting | Prednisone and Either Cyclosporine of Tacrolimus With or Without Mycophenolate Mofetil in Treating Patients With Newly Diagnosed Chronic Graft-Versus-Host Disease
Conditions: Cancer; Graft Versus Host Disease |
| 28. | | Recruiting | Radiolabeled Monoclonal Antibody Therapy Combined With Total-body Irradiation, Allogeneic Peripheral Stem Cell Transplantation, and Immunosuppression Therapy in Treating Older Patients Who Have Advanced Acute Myeloid Leukemia, Myelodysplastic Syndrome, or Chronic Myelomonocytic Leukemia
Conditions: adult acute myeloid leukemia; atypical chronic myeloid leukemia; Chronic Myelomonocytic Leukemia; Graft Versus Host Disease; ... |
| 29. | | Recruiting | Radiolabeled Monoclonal Antibody, Cyclophosphamide, and Total Body Irradiation Followed By Donor Stem Cell Transplantation in Treating Patients With Advanced Acute Myeloid Leukemia
Conditions: adult acute myeloid leukemia; childhood acute myeloid leukemia; secondary acute myeloid leukemia |
| 30. | | Recruiting | Sirolimus as Secondary Therapy in Treating Patients With Chronic Graft-Versus-Host Disease That Did Not Respond to Previous Systemic Treatment
Condition: Graft Versus Host Disease |
| 31. | | Recruiting | Sirolimus, Tacrolimus, and Methotrexate in Preventing Acute Graft-Versus-Host Disease in Patients With Hematologic Cancer Who are Undergoing Donor Stem Cell Transplantation
Conditions: childhood Hodgkin's lymphoma; childhood non-Hodgkin's lymphoma; Graft Versus Host Disease; hematopoietic and lymphoid cancer |
| 32. | | Recruiting | Stem Cell Transplantation in Treating Patients With Previously-Treated Multiple Myeloma
Conditions: stage I multiple myeloma; stage II multiple myeloma; stage III multiple myeloma; refractory plasma cell neoplasm |
| 33. | | Recruiting | Study of Peripheral Stem Cell Transplantation After Chemotherapy and Radiation Therapy in Treating Patients With Metastatic Kidney Cancer
Condition: Stage IV Renal Cell Cancer |
| 34. | | Recruiting | Study of the Emotional Needs of Caregivers of Stem Cell Transplantation Patients
Conditions: Breast Cancer; Endocrine Cancer; female reproductive cancer; hematopoietic and lymphoid cancer; Neuroblastoma; psychosocial effects and treatment |
| 35. | | Recruiting | Study of Total Body Irradiation and Fludarabine Followed By Allogeneic Peripheral Blood Stem Cell or Bone Marrow Transplantation in Combination With Cyclosporine and Mycophenolate Mofetil in Patients With Inherited Disorders
Conditions: Metabolism, Inborn Errors; Granulomatous Disease, Chronic |
| 36. | | Recruiting | Study of Total Body Irradiation in Combination With Allogeneic Peripheral Blood Stem Cell or Bone Marrow Transplantation Followed By Cyclosporine and Mycophenolate Mofetil in High Risk-Patients With Human Immunodeficiency Virus-1
Condition: HIV Infections |
| 37. | | Recruiting | Tacrolimus and Mycophenolate Mofetil in Preventing Graft-Versus-Host Disease in Patients Who Have Undergone Donor Stem Cell Transplantation for Hematologic Cancer
Conditions: childhood Hodgkin's lymphoma; childhood non-Hodgkin's lymphoma; Graft Versus Host Disease; hematopoietic and lymphoid cancer |
| 38. | | Recruiting | Total-Body Irradiation With Or Without Fludarabine Followed By Allogeneic Hematopoietic Stem Cell Transplantation in Treating Patients With Hematologic Malignancies
Conditions: childhood Hodgkin's lymphoma; childhood non-Hodgkin's lymphoma; Leukemia; Lymphoma; plasma cell neoplasm |
| 39. | | Recruiting | Valganciclovir to Prevent Cytomegalovirus Infection in Patients Following Donor Stem Cell Transplantation
Condition: Infection |
